Diabetes is a chronic disease that has become an epidemic; the WHO stating that - as of 2016 - over 422 million people worldwide have diabetes. While people with diabetes are faced with lifelong medication this disease can be treated - and its consequences avoided or delayed - when combining medication with frequent exercise and physical activity, controlled diet, regular screening and treatment for complications. Science is striving to find a diabetes treatment that can cure this chronic disease.
In this section, we aim to include the latest breakthroughs for you to stay up to date with these developments.
This information has been
developed for HCPs regarding the use of Dapagliflozin as adjunct therapy
in Adults with Type 1 Diabetes.
This online education was developed with an unrestricted medical education grant from AstraZeneca and is a medical information resource intended for healthcare professionals, outside of the USA and specifically in Europe, who are interested in medical information related to the use of Dapagliflozin as adjunct therapy in Adults with Type 1 Diabetes. The following resources are shared as medical information only and are not issued as medical advice from ATTD or Astra Zeneca.